Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

T-regulatory cell modulation: the future of cancer immunotherapy?

Nizar, S; Copier, J; Meyer, B; Bodman-Smith, M; Galustian, C; Kumar, D; Dalgleish, A (2009) T-regulatory cell modulation: the future of cancer immunotherapy? BRITISH JOURNAL OF CANCER, 100 (11). 1697 - 1703 (7). ISSN 0007-0920
SGUL Authors: Bodman-Smith, Mark Duncan Copier, John Paul Dalgleish, Angus George

["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (136kB) | Preview
Item Type: Article
Additional Information: PubMed ID: 19384299
Keywords: Animals, Antineoplastic Agents, Clinical Trials as Topic, Humans, Immunotherapy, Neoplasms, T-Lymphocytes, Regulatory, Science & Technology, Life Sciences & Biomedicine, Oncology, T-regulatory, tregs, immunotherapy, ANTITUMOR IMMUNE ACTIVITY, NON-HODGKIN-LYMPHOMA, PHASE-I TRIAL, METASTATIC MELANOMA, DENILEUKIN DIFTITOX, OVARIAN-CARCINOMA, CTLA-4 BLOCKADE, PERIPHERAL-BLOOD, DEPENDENT MANNER, TUMOR-REGRESSION, T-regulatory, tregs, immunotherapy
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BRITISH JOURNAL OF CANCER
ISSN: 0007-0920
Related URLs:
26 May 2009Published
Web of Science ID: WOS:000266517600001
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Publisher's version:

Actions (login required)

Edit Item Edit Item